| Brokerage Reports (Showing 1 to 10 of 12) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
StarMine Author Rating | More Info |
| EPS Accuracy * |
Portfolio Return ** |
| 16-Nov-09 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 18 | $50 | | | View Abstract |
| 13-Nov-09 | Roth Capital Partners, Inc. | Scott R. Henry CFA, Andrew Vaino | Meetings with management: Putting the ship back on course | 9 | $25 | | | View Abstract |
| 5-Nov-09 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 25 | $75 | | | View Abstract |
| 5-Nov-09 | Roth Capital Partners, Inc. | Scott R. Henry CFA, Andrew Vaino | Q3 fundamentals strong, but focus on patents and OTC decision | 7 | $25 | | | View Abstract |
| 30-Oct-09 | Caris & Company | David Moskowitz | DEPO - 3Q As Expected | 9 | $25 | | | View Abstract |
| 30-Oct-09 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 20 | $50 | | | View Abstract |
| 30-Oct-09 | Thomson StreetEvents | N/A | DEPO - Event Transcript of Depomed conference call, Oct. 29, 2009 / 5:00pm ET | 18 | $75 | | | View Abstract |
| 30-Oct-09 | Roth Capital Partners, Inc. | Scott R. Henry CFA, Andrew Vaino | History Shows Now To Be A Good Entry Point | 10 | $25 | | | View Abstract |
| 21-Oct-09 | Caris & Company | James Molloy | DEPO-Que Serada, Serada – Initiating with 1*/Buy | 20 | $50 | | | View Abstract |
| 13-Oct-09 | Roth Capital Partners, Inc. | Research Department | Morning Call Summary | 9 | $25 | | | View Abstract |